NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF), is the world’s leading cancer research foundation. As the world’s number one private funder of multiple myeloma research, the MMRF together with its partners, has transformed treatments and dramatically improved the outlook for myeloma patients over the past decade.
On Saturday, November 19th the MMRF will hold its first 5K Walk/Run in Los Angeles to raise awareness and funds for myeloma research. This program is held across 13 cities and hosts 22,000 participants annually. In each city, MMRF partners with myeloma treatment centers to educate and support patients and caregivers at the event. Race participants include patients, patient family members, caregivers, friends, community leaders, healthcare professionals and researchers.
This inspiring event will be held on November 19th from 9:00 AM to 12:30 PM
at Crystal Springs, Griffith Park, Los Angeles, CA.
The MMRF Spirit of Hope Award will be presented to patient Simon Bray who resides with his family in Los Alamitos. At age 45 Simon had been in the best condition of his life. He was the father of a 2 ½ year old son and his wife was expecting a baby girl. Simon was a horse racing analyst for TVG, when during a routine workout Simon broke a vertebrae in his back. Being a rare fracture, his doctor ordered a battery of tests. In an instant Simon’s life was turned upside down when the diagnosis came back as multiple myeloma. Simon knew even then as a media commentator he had the opportunity to help other patients. Today, Simon works with other patients and caretakers from all over the world building awareness for this rare and complicated blood disease.
About Multiple Myeloma
Multiple myeloma is a cancer of the plasma cell. It is the second most common blood cancer. An estimated 30,330 adults (17,900 men and 12,650 people are predicted to die from the disease.
About the Multiple Myeloma Research Foundation (MMRF)
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $330 million and directs nearly 90% of the total funds to research and related programs. To learn more, visit www.themmrf.org